Published in Int J Clin Pharmacol Ther Toxicol on January 01, 1981
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet (1985) 8.35
Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology (2005) 5.51
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg (2001) 2.79
A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther (2010) 2.74
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56
Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet (1986) 2.50
Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma. Br J Surg (2007) 2.37
Shear wave elastography: a new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. J Clin Endocrinol Metab (2010) 2.29
Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab (1997) 2.25
PHARM--an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med (1984) 2.09
Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab (2001) 2.05
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab (2003) 1.91
Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med (2001) 1.77
IGPHARM: interactive graphic package for pharmacokinetic analysis. Comput Biomed Res (1978) 1.71
Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br J Clin Pharmacol (1975) 1.63
A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. J Biopharm Stat (1995) 1.54
N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia (1975) 1.54
Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A (2000) 1.51
Delayed absorption of phenylbutazone caused by desmethylimipramine in humans. Eur J Pharmacol (1970) 1.47
Hypotensive and renin-suppressing activities of propranolol in hypertensive patients. Clin Sci Mol Med Suppl (1975) 1.46
Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depression. Clin Pharmacol Ther (2012) 1.41
[Intraoperative parathormone assay. The value of assessment of primary hyperparathyroidism in surgery]. J Chir (Paris) (1996) 1.40
[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]. Ned Tijdschr Geneeskd (2000) 1.38
Zolpidem side-effects. Lancet (1993) 1.37
A sensitive gas chromatographic method for the determination of propranolol in human plasma. J Chromatogr (1973) 1.34
Does cerebrovascular disease affect the coupling between neuronal activity and local haemodynamics? Brain (2003) 1.31
Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent. J Chromatogr (1979) 1.30
Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet (1981) 1.29
Duration between onset and time of obtaining initial treatment among people with anxiety and mood disorders: an international survey of members of mental health patient advocate groups. Psychol Med (2000) 1.26
Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet (1976) 1.25
Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res (1999) 1.24
Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus. Eur J Clin Pharmacol (1980) 1.23
Laparoscopic resection of an adrenal hydatid cyst. Eur J Surg (2000) 1.22
Risk and preventive factors of post-traumatic stress disorder (PTSD): alcohol consumption and intoxication prior to a traumatic event diminishes the relative risk to develop PTSD in response to that trauma. J Affect Disord (2001) 1.22
Increased cerebral vasomotor reactivity in migraine with aura: an autoregulation disorder? A transcranial Doppler and near-infrared spectroscopy study. Cephalalgia (2008) 1.22
What is the evidence for endoscopic thyroidectomy in the management of benign thyroid disease? World J Surg (2008) 1.20
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res (1998) 1.19
Further observations on the interactions between phenobarbital and diphenylhydantoin during chronic treatment in the rat. Biochem Pharmacol (1972) 1.18
Interaction between phenobarbital and diphenylhydantoin in animals and in epileptic patients. Ann N Y Acad Sci (1971) 1.16
Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol (1993) 1.15
Metabolism and Pharmacolinetics of Carbamazepine. Drug Metab Rev (1975) 1.15
Diazepam elimination in premature and full term infants, and children. J Perinat Med (1973) 1.15
Protein-deficient pigs cannot maintain reduced glutathione homeostasis when subjected to the stress of inflammation. J Nutr (1995) 1.14
Influence of age on mianserin pharmacokinetics. Psychopharmacology (Berl) (1982) 1.13
Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur J Pharmacol (1978) 1.13
Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. Clin Endocrinol (Oxf) (2008) 1.13
Isolated adrenal metastasis: the role of laparoscopic surgery. World J Surg (2006) 1.12
Pharmacokinetics of nomifensine in man. Psychopharmacologia (1975) 1.12
Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab (2000) 1.09
Origin of intact lactoferrin and its DNA-binding fragments found in the urine of human milk-fed preterm infants. Evaluation by stable isotopic enrichment. Pediatr Res (1991) 1.08
Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol (1986) 1.08
Clincial pharmacokinetics in neonates. Clin Pharmacokinet (1976) 1.07
Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation. Proc Natl Acad Sci U S A (1991) 1.06
Prevalence of nightmares and their relationship to psychopathology and daytime functioning in insomnia subjects. Sleep (1997) 1.06
Endocrine surgical technique: endoscopic thyroidectomy via the lateral approach. Surg Endosc (2005) 1.05
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Alzheimer Dis Assoc Disord (1998) 1.05
Neuroimaging experimental studies on brain plasticity in recovery from stroke. Eura Medicophys (2007) 1.04
Limited value of 18F-F-DOPA PET to localize pancreatic insulin-secreting tumors in adults with hyperinsulinemic hypoglycemia. J Clin Endocrinol Metab (2009) 1.03
Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging (2001) 1.03
Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry (1997) 1.03
Monosodium glutamate and the Chinese restaurant syndrome. Nature (1970) 1.02
Psychiatric morbidity and comorbidity following accidental man-made traumatic events: incidence and risk factors. Eur Arch Psychiatry Clin Neurosci (2000) 1.02
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Clin Endocrinol (Oxf) (2008) 1.01
Simple sensitive and specific gas chromatographic method for the quantification of diltiazem human body fluids. J Chromatogr (1977) 1.01
Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue. Epilepsia (1988) 1.01
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect. Br J Clin Pharmacol (1976) 1.01
Rapid and sensitive method for determination of haloperidol in human samples using nitrogen-phosphorus selective detection. J Chromatogr (1978) 0.99
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med (1998) 0.99
Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities. Clin Endocrinol (Oxf) (2011) 0.99
Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg (2001) 0.98
The "false" nonrecurrent inferior laryngeal nerve. Surgery (2000) 0.97
Studies on plasma protein binding of carbamazepine. Pharmacol Res Commun (1974) 0.97
Biochemical aspects of Huntington's chorea. J Neurol Neurosurg Psychiatry (1977) 0.97
Adaptive-optimal design in PET occupancy studies. Clin Pharmacol Ther (2010) 0.96
Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. Epilepsia (1975) 0.95
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects. Neurology (1976) 0.95
EEG profile of intravenous zolpidem in healthy volunteers. Psychopharmacology (Berl) (1994) 0.95
Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology (2001) 0.95
The prognostic significance of isolated systolic hypertension in the elderly. Results of a ten year longitudinal survey. Clin Exp Hypertens A (1982) 0.94
Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. J Psychiatr Res (1999) 0.94
Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging (2008) 0.94
Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration. Br J Clin Pharmacol (1980) 0.94
Adaptive regulation of intestinal lysine metabolism. Proc Natl Acad Sci U S A (2000) 0.94
Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa. Antimicrob Agents Chemother (1991) 0.93
Cerebral complications of hypertension. J Hum Hypertens (2001) 0.93
Monoamine acid metabolites and cerebrospinal fluid dynamics in normal pressure hydrocephalus: preliminary results. J Neurol Neurosurg Psychiatry (1975) 0.93
Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies. Eur J Clin Pharmacol (1996) 0.93
Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012. J Nutr Health Aging (2013) 0.92
[Neuropathological study of 12 centenarians: the incidence of Alzheimer type senile dementia is not particularly increased in this group of very old patients]. Rev Neurol (Paris) (1986) 0.92
Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol (2001) 0.92